Allianz’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.43M Sell
14,829
-568
-4% -$273K 0.08% 151
2026
Q1
$7.57M Sell
15,397
-1,131
-7% -$614K 0.08% 139
2025
Q4
$9.58M Buy
16,528
+976
+6% +$552K 0.12% 98
2025
Q3
$7.54M Buy
15,552
+200
+1% +$93.1K 0.16% 111
2025
Q2
$6.22M Sell
15,352
-470
-3% -$197K 0.15% 123
2025
Q1
$7.87M Buy
15,822
+762
+5% +$413K 0.21% 102
2024
Q4
$7.81M Sell
15,060
-622
-4% -$342K 0.2% 100
2024
Q3
$9.7M Buy
15,682
+1,941
+14% +$1.15M 0.26% 80
2024
Q2
$7.6M Sell
13,741
-1,219
-8% -$698K 0.22% 101
2024
Q1
$8.69M Buy
+14,960
New +$8.39M 0.27% 87

Other funds holding TMO

Allianz's TMO Position: Q2 2026 in Review

Allianz reduced its Thermo Fisher Scientific (TMO) stake by 3.7% in Q2 2026, selling an estimated $273K and leaving 14,829 shares worth $7.43M. The position accounts for 0.08% of the portfolio, ranked #151.

Allianz first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.7M in Q3 2024. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Allianz held 14,829 shares of Thermo Fisher Scientific worth $7.43M as of Q2 2026.
  • Allianz sold 568 Thermo Fisher Scientific shares in Q2 2026, an estimated $273K.
  • Thermo Fisher Scientific made up 0.08% of Allianz's portfolio in Q2 2026, its #151 holding.
  • Allianz first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Thermo Fisher Scientific position peaked at $9.7M in Q3 2024.
  • 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.